Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Vano YA"'
Autor:
Daban, A, Gonnin, C, Phan, L, Saldmann, A, Granier, C, Lillo-Lelouet, A, Le Beller, C, Pouchot, J, Weiss, l, Tartour, E, Fabre, E, Medioni, J, Oudard, S, Vano, YA, Dragon-Durey, MA, Simonaggio, A.
Publikováno v:
OncoImmunology; 2023, Vol. 12 Issue 1, p1-9, 9p
Publikováno v:
Bulletin du Cancer. 96:647-658
One million people worldwide are affected by colorectal cancer (CRC) every year, resulting in 500,000 deaths. Incidence rate varies widely according to areas. It has been much more common in high-income countries. This trend begins to be reversed, wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f33699e8dcd820256066f80fae241966
https://doi.org/10.1684/bdc.2009.0874
https://doi.org/10.1684/bdc.2009.0874
Autor:
Barthélémy P; Department of Medical Oncology, Institut de Cancérologie Strasbourg Europe, Strasbourg. Electronic address: p.barthelemy@icans.eu., Albigès L; Department of Medical Oncology, Gustave Roussy Cancer Campus, Paris., Escudier B; Department of Medical Oncology, Gustave Roussy Cancer Campus, Paris., Narciso B; Department of Medical Oncology, Centre Hospitalier Universitaire de Tours, Tours., Bigot P; Department of Urology, Centre Hospitalier Universitaire d'Angers, Angers., Chehimi M; Department of Medical Oncology and Hematology, Centre Hospitalier de Saint-Quentin, Saint-Quentin., Emambux S; Department of Medical Oncology, Centre Hospitalier Universitaire de Poitiers, Poitiers., Calcagno F; Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon, Besançon., Mouillet G; Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon, Besançon., Eymard JC; Department of Medical Oncology, Institut Jean Godinot, Reims CEDEX., Schlürmann F; Department of Medical Oncology, Centre Hospitalier Intercommunal Quimper, Quimper., Bailly S; Department of Thoracic Oncology, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand., Garbay D; Department of Medical Oncology, Clinique Tivoli-Ducos, Bordeaux., Berdah JF; Department of Medical Oncology and Radiotherapy, Hôpital privé Toulon Hyères-Sainte Marguerite, Hyères., Palmaro MB; Department of Medical Oncology, Hôpital Nord, Marseille., Goupil MG; Department of Medical Oncology, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux., Spaeth D; Department of Medical Oncology, Polyclinique de Gentilly, Nancy., Néré S; Department of Medical Affairs, Bristol Myers Squibb, Paris., Quentric C; Department of Medical Affairs, Bristol Myers Squibb, Paris., Vano YA; Department of Medical Oncology, Hôpital Européen Georges Pompidou, APHP Centre-Université de Paris, Paris, France., Thiery-Vuillemin A; Department of Medical Oncology, Centre Hospitalier Universitaire de Besançon, Besançon.
Publikováno v:
ESMO open [ESMO Open] 2024 Jul; Vol. 9 (7), pp. 103602. Date of Electronic Publication: 2024 Jun 18.
Évolution de la prise en charge du cancer du rein : place des biomarqueurs et facteurs pronostiques.
Autor:
Vano YA; Service d'Oncologie Médicale, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, AP-HP. Centre - Université Paris Cité, Paris; Centre de Recherche des Cordeliers, INSERM, Université Paris Cité, Sorbonne Université, F-Paris. Electronic address: yann.vano@aphp.fr.
Publikováno v:
Bulletin du cancer [Bull Cancer] 2024 Jun; Vol. 111 (6S1), pp. 6S1-6S3.
Autor:
Blanchet B; Université de Paris, CNRS, INSERM, CiTCoM, U1268, F-75006, Paris, France. benoit.blanchet@aphp.fr.; Biologie du Médicament - Toxicologie, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France. benoit.blanchet@aphp.fr.; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France. benoit.blanchet@aphp.fr., Xu-Vuilard A; Department of Medical Oncology, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Georges Pompidou, Paris, France., Jouinot A; Department of Medical Oncology, ARIANE, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France.; Université Paris Cité, Institut Cochin, Inserm U1016, CNRS UMR8104, Paris, France., Puisset F; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.; Oncopole Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059, Toulouse, France., Combarel D; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.; Faculté de pharmacie, Université Paris Saclay, Orsay, France.; Medical School, University of Paris XI, Saclay, France., Huillard O; Department of Medical Oncology, ARIANE, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France., Le Louedec F; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.; Oncopole Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059, Toulouse, France., Thomas F; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.; Oncopole Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059, Toulouse, France.; CRCT, Cancer Research Center of Toulouse, Inserm U1037, Université Paul Sabatier, 31037, Toulouse, France., Teixeira M; Department of Oncological Medicine, Gustave Roussy, Villejuif, France.; Medical School, University of Paris XI Saclay, Saclay, France., Flippot R; Department of Oncological Medicine, Gustave Roussy, Villejuif, France.; Medical School, University of Paris XI Saclay, Saclay, France.; Laboratoire d'immunomonitoring en oncologie, CNRS3655 & INSERM US23, Université Paris Saclay, Paris, France., Mourey L; Oncopole Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059, Toulouse, France., Albiges L; Department of Oncological Medicine, Gustave Roussy, Villejuif, France.; Medical School, University of Paris XI Saclay, Saclay, France., Pudlarz T; Department of Medical Oncology, Assistance Publique Hôpitaux de Paris, Hôpital Saint Antoine, Paris, France., Joly C; Department of Medical Oncology, Assistance Publique Hôpitaux de Paris, Hôpital Henri Mondor, Université de Paris Est, Créteil, France., Tournigand C; Department of Medical Oncology, Assistance Publique Hôpitaux de Paris, Hôpital Henri Mondor, Université de Paris Est, Créteil, France., Chauvin J; Lixoft, 92160, Antony, France., Puszkiel A; Biologie du Médicament - Toxicologie, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France.; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.; Université Paris Cité, Inserm, UMR-S1144, Paris, France., Chatelut E; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.; Oncopole Claudius-Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, 31059, Toulouse, France.; CRCT, Cancer Research Center of Toulouse, Inserm U1037, Université Paul Sabatier, 31037, Toulouse, France., Decleves X; Biologie du Médicament - Toxicologie, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France.; Groupe de Pharmacologie Clinique Oncologique GPCO-Unicancer, Paris, France.; Université Paris Cité, Inserm, UMR-S1144, Paris, France., Vidal M; Université de Paris, CNRS, INSERM, CiTCoM, U1268, F-75006, Paris, France.; Biologie du Médicament - Toxicologie, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France., Goldwasser F; Department of Medical Oncology, ARIANE, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Paris, France., Oudard S; Department of Medical Oncology, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Georges Pompidou, Paris, France.; Université de Paris Cité, INSERM U970, PARCC, Paris, France., Medioni J; Department of Medical Oncology, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Georges Pompidou, Paris, France., Vano YA; Department of Medical Oncology, Institut du Cancer Paris CARPEM, Assistance Publique Hôpitaux de Paris, Hôpital Georges Pompidou, Paris, France.; Université de Paris Cité, UMR_S1138-INSERM, Paris, France.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Apr; Vol. 130 (6), pp. 961-969. Date of Electronic Publication: 2024 Jan 25.
Autor:
Revel M; Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, Inflammation, Complement and Cancer team, Paris, France., Rezola Artero M; Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, Inflammation, Complement and Cancer team, Paris, France.; Department of Bacteriology and Immunology, Haartman Institute, and Translational Immunology Research Program, University of Helsinki, Helsinki, Finland., Hamidi H; Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, Inflammation, Complement and Cancer team, Paris, France.; Laboratoire d'Immunologie, Hôpital Européen Georges Pompidou, APHP, Paris, France., Grunenwald A; Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, Inflammation, Complement and Cancer team, Paris, France.; Department of Nephrology and Hemodialysis, Service de néphrologie - hémodialyse, Poissy, France., Blasco L; Laboratoire d'Immunologie, Hôpital Européen Georges Pompidou, APHP, Paris, France., Vano YA; Hôpital Européen Georges-Pompidou, Oncology Department, Assistance Publique Hopitaux de Paris, Université Paris Cité, Paris, France., Marie Oudard S; Hôpital Européen Georges-Pompidou, Oncology Department, Assistance Publique Hopitaux de Paris, Université Paris Cité, Paris, France., Sanchez-Salas R; Department of Urology Institut Mutualiste Montsouris, Paris, France., Macek P; Department of Urology Institut Mutualiste Montsouris, Paris, France., Rodriguez Sanchez L; Department of Urology Institut Mutualiste Montsouris, Paris, France., Cathelineau X; Department of Urology Institut Mutualiste Montsouris, Paris, France., Vedié B; Hôpital Européen Georges-Pompidou, Department of Biochemistry, Assistance Publique Hopitaux de Paris, Paris, France., Sautes-Fridman C; Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, Inflammation, Complement and Cancer team, Paris, France.; Equipe labellisée Ligue contre le Cancer, Paris., Herman Fridman W; Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, Inflammation, Complement and Cancer team, Paris, France.; Equipe labellisée Ligue contre le Cancer, Paris., Roumenina LT; Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, Inflammation, Complement and Cancer team, Paris, France., Dragon-Durey MA; Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, Inflammation, Complement and Cancer team, Paris, France.; Laboratoire d'Immunologie, Hôpital Européen Georges Pompidou, APHP, Paris, France.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2024 Mar 13; Vol. 13 (1), pp. 2328433. Date of Electronic Publication: 2024 Mar 13 (Print Publication: 2024).
Autor:
Lu X; Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, 67400 Illkirch, France., Vano YA; Department of Medical Oncology, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, AP-HP, Université Paris Cité, Paris, France; Centre de Recherche Cordeliers, INSERM 1138, Université de Paris Cité, Sorbonne Université, Equipe labellisée Ligue contre le Cancer, 75006 Paris, France., Su X; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Helleux A; Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, 67400 Illkirch, France., Lindner V; Department of Pathology, Strasbourg University Hospital, Strasbourg, France., Mouawad R; Department of Medical Oncology, Sorbonne University, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France., Spano JP; Department of Medical Oncology, Sorbonne University, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France., Rouprêt M; Sorbonne University, GRC 5 P, UKredictive Onco-Uro, AP-HP, Urology, Pitié-Salpêtrière Hospital, 75013 Paris, France., Compérat E; Department of Pathology, Sorbonne University, AP-HP, Hôpital Tenon, Paris, France., Verkarre V; Department of Pathology, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, AP-HP, Université Paris Cité, Paris, France., Sun CM; Centre de Recherche Cordeliers, INSERM 1138, Université de Paris Cité, Sorbonne Université, Equipe labellisée Ligue contre le Cancer, 75006 Paris, France., Bennamoun M; Department of Medical Oncology, Institut Mutualiste Montsouris, Paris, France., Lang H; Department of Urology, Strasbourg University Hospital, Strasbourg, France., Barthelemy P; Department of Medical Oncology, Strasbourg University, Institut de Cancérologie de Strasbourg, Strasbourg, France., Cheng W; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, P.R. China., Xu L; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, P.R. China., Davidson I; Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, 67400 Illkirch, France., Yan F; Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, P.R. China., Fridman WH; Centre de Recherche Cordeliers, INSERM 1138, Université de Paris Cité, Sorbonne Université, Equipe labellisée Ligue contre le Cancer, 75006 Paris, France., Sautes-Fridman C; Centre de Recherche Cordeliers, INSERM 1138, Université de Paris Cité, Sorbonne Université, Equipe labellisée Ligue contre le Cancer, 75006 Paris, France., Oudard S; Centre de Recherche Cordeliers, INSERM 1138, Université de Paris Cité, Sorbonne Université, Equipe labellisée Ligue contre le Cancer, 75006 Paris, France., Malouf GG; Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, 67400 Illkirch, France; Department of Medical Oncology, Strasbourg University, Institut de Cancérologie de Strasbourg, Strasbourg, France. Electronic address: maloufg@igbmc.fr.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2023 Nov 21; Vol. 4 (11), pp. 101287. Date of Electronic Publication: 2023 Nov 14.
Autor:
André T; Saint-Antoine Hospital, INSERM, Unité Mixte de Recherche Scientifique 938, and SIRIC CURAMUS, Sorbonne University, Paris, France., Berton D; GINECO and Institut de Cancerologie de l'Ouest, Centre René Gauducheau, Saint-Herblain, France., Curigliano G; European Institute of Oncology, IRCCS, Milan, Italy.; Department of Medical Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Sabatier R; Department of Medical Oncology, Institut Paoli-Calmettes, CRCM, INSERM, CNRS, Aix-Marseille University, Marseille, France., Tinker AV; BC Cancer-Vancouver, Vancouver, British Columbia, Canada., Oaknin A; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain., Ellard S; BC Cancer-Kelowna, Kelowna, British Columbia, Canada., de Braud F; Ordinario di Oncologia Medica Direttore Scuola di Specialità in Oncologia Medica Università di Milano, Direttore Dipartimento Oncologia e Ematoncologia Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Arkenau HT; Sarah Cannon Research Institute UK Limited, London, United Kingdom., Trigo J; Medical Oncology Department, Hospital Virgen de la Victoria IBIMA, Malaga, Spain., Gravina A; Clinical Trials Unit, Instituto Nazionale Tumori, IRCCS, Fondazione 'G. Pascale,' Naples, Italy., Kristeleit R; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Moreno V; START Madrid FJD, Hospital Fundación Jiménez Díaz, Madrid, Spain., Abdeddaim C; Centre de Lutte Contre le Cancer-Centre Oscar Lambret, Lille, France., Vano YA; Department of Medical Oncology, Hôpital Européen Georges-Pompidou, Institut du Cancer Paris CARPEM, AP-HP Centre-Université Paris Cité, Paris, France., Samouëlian V; Gynecologic Oncology Division, Centre Hospitalier de l'Université de Montréal (CHUM), Centre de Recherche du CHUM, and Université de Montréal, Montreal, Quebec, Canada., Miller R; University College London, St Bartholomew's Hospital London, London, United Kingdom., Boni V; NEXT Oncology Hospital Universitario Quirónsalud Madrid, Madrid, Spain., Torres AA; Department of Medical Oncology, Hospital Universitario Miguel Servet and IIS Aragon, Zaragoza, Spain., Gilbert L; Division of Gynecologic Oncology, McGill University Health Centre, Montreal, Quebec, Canada., Brown J; Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina., Dewal N; GSK, Pennington, New Jersey., Dabrowski C; GSK, Waltham, Massachusetts., Antony G; GSK, Hertfordshire, United Kingdom., Zografos E; GSK, London, United Kingdom., Veneris J; GSK, Waltham, Massachusetts., Banerjee S; The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom.
Publikováno v:
JAMA network open [JAMA Netw Open] 2023 Nov 01; Vol. 6 (11), pp. e2341165. Date of Electronic Publication: 2023 Nov 01.
Autor:
Davidson G; Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, Illkirch, France., Helleux A; Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, Illkirch, France., Vano YA; Department of Medical Oncology, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, APHP, Université Paris Cité, Paris, France., Lindner V; Department of Pathology, Strasbourg University Hospital, Strasbourg, France., Fattori A; Department of Pathology, Strasbourg University Hospital, Strasbourg, France., Cerciat M; Genomeast platform, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, 67400 Illkirch, France., Elaidi RT; Association pour la Recherche sur les Thérapeutiques Innovantes en Cancérologie, Paris, France., Verkarre V; Department of Pathology, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, APHP, Université Paris Cité, Paris, France., Sun CM; Centre des Cordeliers, INSERM, Université de Paris Cité, Sorbonne Université, Equipe labellisée Ligue contre le Cancer, Paris, France., Chevreau C; Department of Medical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France., Bennamoun M; Department of Medical Oncology, Institut Mutualiste Montsouris, Paris, France., Lang H; Department of Urology, Strasbourg University Hospital, Strasbourg, France., Tricard T; Department of Urology, Strasbourg University Hospital, Strasbourg, France., Fridman WH; Centre des Cordeliers, INSERM, Université de Paris Cité, Sorbonne Université, Equipe labellisée Ligue contre le Cancer, Paris, France., Sautes-Fridman C; Centre des Cordeliers, INSERM, Université de Paris Cité, Sorbonne Université, Equipe labellisée Ligue contre le Cancer, Paris, France., Su X; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Plassard D; Genomeast platform, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, 67400 Illkirch, France., Keime C; Genomeast platform, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, 67400 Illkirch, France., Thibault-Carpentier C; Genomeast platform, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, 67400 Illkirch, France., Barthelemy P; Department of Medical Oncology, Strasbourg University, Institut de Cancérologie de Strasbourg, Strasbourg, France., Oudard SM; Department of Medical Oncology, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, APHP, Université Paris Cité, Paris, France., Davidson I; Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, Illkirch, France., Malouf GG; Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, Illkirch, France.; Department of Medical Oncology, Strasbourg University, Institut de Cancérologie de Strasbourg, Strasbourg, France.
Publikováno v:
Cancer research [Cancer Res] 2023 Sep 01; Vol. 83 (17), pp. 2952-2969.
Autor:
Alhalabi O; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Thouvenin J; Institut de Cancérologie des Hospices Civils de Lyon, Lyon, France.; Institut de Cancérologie Strasbourg Europe (ICANS/HUS), Strasbourg, France., Négrier S; Université Lyon I, Centre Léon Bérard, Lyon, France., Vano YA; Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, AP-HP.Centre-Université de Paris, Paris, France., Campedel L; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France., Hasanov E; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Bakouny Z; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Hahn AW; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Bilen MA; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Msaouel P; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Choueiri TK; Dana-Farber Cancer Institute, Boston, MA, USA., Viswanathan SR; Dana-Farber Cancer Institute, Boston, MA, USA., Sircar K; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Albiges L; Institut Gustave Roussy, Villejuif, France., Malouf GG; Institut de Cancérologie Strasbourg Europe (ICANS/HUS), Strasbourg, France., Tannir NM; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
The oncologist [Oncologist] 2023 May 08; Vol. 28 (5), pp. 433-439.